These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3435939)

  • 1. Studies on hypolipidemic agents. V. Synthesis and esterase-inhibitory activity of 2-(1,4- and 4,4-dialkylcyclohexyl)-2-oxoethyl arenesulfonates.
    Ogawa K; Terada T; Muranaka Y; Hamakawa T; Fujii S
    Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4130-6. PubMed ID: 3435939
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on hypolipidemic agents. IV. Syntheses and biological activities of trans- and cis-2-(4-alkylcyclohexyl)-2-oxoethyl arenesulfonates.
    Ogawa K; Terada T; Muranaka Y; Hamakawa T; Ohta S; Okamoto M; Fujii S
    Chem Pharm Bull (Tokyo); 1987 Aug; 35(8):3276-83. PubMed ID: 3427711
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on hypolipidemic agents. II. Synthesis of 1-arenesulfonyloxy-2-alkanone derivatives as potent esterase inhibitors and hypolipidemic agents.
    Ogawa K; Terada T; Muranaka Y; Hamakawa T; Hashimoto S; Fujii S
    Chem Pharm Bull (Tokyo); 1986 Aug; 34(8):3252-66. PubMed ID: 3791497
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on hypolipidemic agents. III. Synthesis and esterase-inhibitory activity of omega-cycloalkyl-2-oxoalkyl arenesulfonates.
    Ogawa K; Terada T; Muranaka Y; Hamakawa T; Fujii S
    Chem Pharm Bull (Tokyo); 1987 Jun; 35(6):2426-36. PubMed ID: 3664839
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on hypolipidemic agents. II. Synthesis and pharmacological properties of alkylpyrazole derivatives.
    Seki K; Isegawa J; Fukuda M; Ohki M
    Chem Pharm Bull (Tokyo); 1984 Apr; 32(4):1568-77. PubMed ID: 6467462
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of hypolipidemic agents. I. Syntheses and hypolipidemic activities of 1-substituted 2-alkanone derivatives.
    Ogawa K; Terada T; Muranaka Y; Hamakawa T; Hashimoto S; Fujii S
    Chem Pharm Bull (Tokyo); 1986 Mar; 34(3):1118-27. PubMed ID: 3731335
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of 5-alkyl-4-oxazoleacetic acid derivatives with hypolipidemic activities.
    Seki M; Moriya T; Matsumoto K; Takashima K; Mori T; Odawara A; Takeyama S
    Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4435-40. PubMed ID: 3246011
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypolipidemic 4,5-dihydro-4-oxo-5,5-disubstituted-2-furancarboxylic acids.
    Jirkovsky I; Cayen MN
    J Med Chem; 1982 Oct; 25(10):1154-6. PubMed ID: 7143351
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypolipidemic activity of rifamycin derivatives.
    Traxler P; Kump W; Mueller K; Tosch W
    J Med Chem; 1990 Feb; 33(2):552-60. PubMed ID: 2299623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterocyclic analogues of chlorcyclizine with potent hypolipidemic activity.
    Ashton MJ; Ashford A; Loveless AH; Riddell D; Salmon J; Stevenson GV
    J Med Chem; 1984 Oct; 27(10):1245-53. PubMed ID: 6148419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on hypolipidemic agents. II. 3-(4-Phenoxybenzoyl)-propionic acid derivatives.
    Tomisawa K; Kameo K; Matsunaga T; Saito S; Hosoda K; Asami Y; Sota K
    Chem Pharm Bull (Tokyo); 1985 Jun; 33(6):2386-94. PubMed ID: 4064197
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of a new hypolipidemic agent, 2-(trans-4-isobutylcyclohexyl)-2-oxoethyl benzenesulphonate, and its metabolite by high-performance liquid chromatography and gas chromatography-mass fragmentography in human biological materials.
    Maniwa M; Umeno Y; Marunaka T
    J Chromatogr; 1988 Dec; 433():282-7. PubMed ID: 3235558
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on hypolipidemic agents. I. 3-Benzoylglycidic acid derivatives.
    Tomisawa K; Kameo K; Goi M; Sota K
    Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):3066-74. PubMed ID: 6518588
    [No Abstract]   [Full Text] [Related]  

  • 14. [New derivatives of clofibrate and probucol. Preliminary study of their hypolipemic activity].
    de Meglio P; Ravenna F; Manzardo S; Gentili P; Riva M
    Farmaco Sci; 1985 Nov; 40(11):833-44. PubMed ID: 4085644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on hypolipidemic agents. IV. 3-[4-(Phenylthio)benzoyl]propionic acid derivatives.
    Kameo K; Asami Y; Ogawa K; Matsunaga T; Saito S; Tomisawa K; Sota K
    Chem Pharm Bull (Tokyo); 1989 May; 37(5):1260-7. PubMed ID: 2630091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of hypolipidemic silybin analog 3',4'-ethylenedioxyflavonoids.
    Litkei GY; Patonay T; Bognár R; Khilja V; Aitmambetov A; Turov A; Babichev F
    Pharmazie; 1984 Nov; 39(11):741-4. PubMed ID: 6531375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric alpha-substituted phenethylamines. IV. The synthesis and analgesic activity of optically pure (S) and (R)-1-cyclohexyl- and 1-cyclohexenyl-2-phenylethylamines.
    Takahashi H; Chida Y; Suzuki T; Onishi H; Yanaura S
    Chem Pharm Bull (Tokyo); 1984 Jul; 32(7):2714-23. PubMed ID: 6499084
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on hypolipidemic agents. I. Synthesis of 1,3-dioxolanes and 1,3-dioxanes.
    Eriguchi A; Takegoshi T
    Chem Pharm Bull (Tokyo); 1982 Feb; 30(2):428-39. PubMed ID: 7094144
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on hypolipidemic agents. III. Omega-(4-phenoxybenzoyl)-alkanoic acid derivatives.
    Tomisawa K; Kameo K; Matsunaga T; Saito S; Hosoda K; Asami Y; Sota K
    Chem Pharm Bull (Tokyo); 1986 Feb; 34(2):701-12. PubMed ID: 3708726
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypobetalipoproteinemic agents. 3. Variation of the polycyclic portion of 4-(1-adamantyloxy)aniline.
    Heyd WE; Bell LT; Heystek JR; Schurr PE; Day CE
    J Med Chem; 1982 Sep; 25(9):1101-3. PubMed ID: 7131490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.